STEMLINE THERAPEUTICS INC 4
4 · STEMLINE THERAPEUTICS INC · Filed May 26, 2016
Insider Transaction Report
Form 4
ZUERBLIS KENNETH J
Director
Transactions
- Award
Stock Options (right to buy)
2016-05-25+34,000→ 34,000 totalExercise: $6.78From: 2017-05-25Exp: 2026-05-25→ Common Stock (34,000 underlying)
Footnotes (1)
- [F1]The options will vest according to the following schedule: one-third on each of 5/25/2017, 5/25/2018, and 5/25/2019.